top of page
About us?

The Research Unit of the Astorga Oncology Clinic was created in 2015 with the purpose of contributing to the generation of scientific knowledge, through the development of studies with data from our patients, focused on Oncology and Hematology for the adult population. We have experience in academic studies on topics such as: ovarian cancer, lung cancer and breast cancer. As a result, these studies have been published in scientific journals such as the Journal of Investigative Medicine, among others. Some of these projects have been presented at national and international conferences such as the 5th National Congress of Research in Hematology and Oncology ACHO (Colombian Association of Hematology and Oncology) and the Congress of the American Society of Clinical Oncology (ASCO).

We have experience in participating in variousclinical trials¹ to evaluate treatments for lung, kidney, cervix (uterine cervix), breast and other solid tumors.


The Research Unit adheres to the procedures and standards of behavior required for the responsible development of its scientific activities, including respect for the rights and safety of patients, the development of processes and practices that guarantee accurate and optimal scientific data. quality, as well as compliance with current national and international standards such asHelsinki Declaration² and theGood Clinical Practices³.


Our research group is made up of highly trained personnel, with experience and training in research methodology, epidemiology, clinical oncology, radiotherapy, and related disciplines.


1. Clinical study, clinical trial or research study:

Clinical research focuses on the generation of new alternatives for the prevention, diagnosis and treatment of diseases. This is done through research in people, after conducting various studies in vitro (in a laboratory), and demonstrating that the treatments or interventions are safe and effective in animals.


Clinical trials are carried out with the objective of evaluating the safety and efficacy of new therapies, when comparing them with those that are normally used, in order to bring new treatment options to the market, which can improve the health and quality of life of patients. patients.


2. Declaration of Helsinki:

Any medication, procedure, intervention or medical device used to treat disease must go through a rigorous process to demonstrate that it is safe and effective. In 1964, the World Medical Association established the international ethical principles that should govern the conduct of clinical studies in humans. These standards are periodically reviewed and updated.


3. Good Clinical Practices:

They are international standards to ensure the ethical and scientific quality of studies carried out on human beings. All research carried out must comply with specific research regulations within each country. These standards are based on this international regulation.

Our team

Dr. Beatriz Elena Preciado Franco

Director of the Research Unit

Dr. Camila Lema Calidonio

Research Development Coordinator

Katerin Puerta Alzate

Clinical Studies Coordinator

Dr. Mateo Pineda Alvarez

i doctorresearch